Skip to main content

Table 3 Reactional status of UMDT/CT-BR leprosy patients according to operational classification

From: Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil

 

PB N (%)

MB N (%)

Total N (%)

Reactions

29 (3.9)

389 (51.6)

418 (55.5)

 RR

10 (1.3)

128 (17)

138 (18.3)

 ENL

0

41 (5.4)

41 (5.4)

 RR + Neu

3 (0.4)

25 (3.3)

28 (3.7)

 ENL + Neu

0

7 (0.9)

7 (0.9)

 Neuritis

16 (2.1)

133 (17.7)

149 (19.8)

 Others

0

55 (7.3)

55 (7.3)

Reaction-free

129 (17.1)

206 (27.4)

335 (44.5)

Total

158 (21)

595 (79)

753 (100)

  1. X 2 (6) = 118.97; p < 0.001
  2. PB Paucibacillary Leprosy, MB Multibacillary Leprosy, RR Reversal Reaction, ENL Erythema Nodosum Leprosum, Neu Neuritis, Others Other Manifestations